Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


WAISMANN METHOD® Medical Director Expresses Concern about Shift in Opioid Drug Use
Abuse-Deterrent Formulation of OxyContin Allegedly Responsible for Increase in Heroin Users

BEVERLY HILLS, Calif., Jan. 2, 2013 /PRNewswire/ -- An "abuse-proof" formulation of OxyContin may have helped reduce the number of patients abusing the drug, but Dr. Michael Lowenstein, medical director for WAISMANN METHOD® opiate detoxification and treatment, is voicing alarm at recent data showing it may have consequentially resulted in a sharp increase in heroin and other opioid drug use.

"After the new abuse-resistant OxyContin was released, I expressed concerns that it could encourage patients to migrate to other, sometimes more dangerous opioid drugs," said Dr. Lowenstein. "Two years later this fear has become a reality, as the New England Journal of Medicine reported a huge increase in high-potency prescription opioids while heroin use nearly doubled.  Patient education is more important now than ever before, so we can work to actually help alleviate people of their addictions to opioids rather than replace one narcotic for another."

The NEJM study scrutinized data from 2,566 patients with opioid dependence, and found that abuse of OxyContin as the primary drug decreased from 35.6 percent to 12.8 percent from July 1, 2009 to March 31, 2012. During the same time period, respondent figures showed a rise in use of opioids, like hydrocodone and oxycodone, and powerful opioids, like fentanyl and hydromorphone, which rose from 20.1 percent to 32.3 percent. Data collected from WAISMANN METHOD® patients between January and December 2011 also showed similar trends. During this time, there was an 80 percent decrease in the number of patients treated for OxyContin dependency compared to those in 2010. At the same time, oxycodone patients treated at the facility went up by 35 percent.

According to the NEJM study, heroin was the most common opioid being used among the 66 percent who indicated they had switched after the abuse-resistant OxyContin was released.  Qualitative responses from the study indicated many patients who switched to heroin did so because it was easier to obtain and more economical than prescription drugs. One participant said, "Most people that I know don't use OxyContin to get high anymore. They have moved on to heroin [because] it is easier to use, much cheaper and easily available."

"We want patients struggling with opioid addiction to know that there are true solutions, and that they don't have to continue to put their lives in danger by using prescription painkillers or switching to illicit street drugs like heroin," continued Dr. Lowenstein. "Abuse-resistant drugs are not the answer, and we in the medical community have a responsibility to do more for our patients so they can eventually live drug-free lives."

For more information about WAISMANN METHOD® treatment and detoxification please visit opiates.com.  For interviews contact Nicolette Surh at 877-975-3423 or send an email to Nicolette(at)rkpr(dot)net.

About WAISMANN METHOD® Treatment

WAISMANN METHOD® opiate treatment and detox is a safe and proven protocol for opiate dependency that utilizes the most advanced medical and psychological techniques available. Together Michael H. Lowenstein M.D., Clifford Bernstein M.D. and Clare Waismann, Registered Addiction Specialist (RAS) created a treatment protocol based on a foundation of safety, success and respect.  Our detoxification and aftercare programs are customized to each patient's individual needs and dependency history, combining the most advanced medical treatment with personalized assessment and aftercare. From rapid opiate detoxification under sedation, to medically assisted detoxification and managed care at Domus Retreat, our doctors, therapists and staff work with patients to create personalized treatment and aftercare plans that ensure a healthy and effective transition to life without opiates.  WAISMANN METHOD® patients achieve an extraordinarily high success rate because the treatment doesn't take a cookie cutter approach to addressing opiate dependency. We always put treatment and care over blame and punishment. For more information, please visit opiates.com.

SOURCE WAISMANN METHOD®

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
DevOps Summit at Cloud Expo 2014 Silicon Valley was a terrific event for us. The Qubell booth was crowded on all three days. We ran demos every 30 minutes with folks lining up to get a seat and usually standing around. It was great to meet and talk to over 500 people! My keynote was we...

#IoT #IDM #SDAS #infosec

As the Internet of Things continues to expand (and it is expanding rapidly) the issue of access to applications is going to get a lot more messy.

One of the benefits of cloud, so I'm told, is it is "easy access" for everyone...

#DevOps

App deployment should be viewed as a comprehensive, end to end process.But we treat it today like each silo is a fork in a project that never merges back together, causing disjointed operations, reporting, measurement and ultimately, failure to meet business priori...

Cryptocurrencies have gained traction in the past half-decade for a variety of reasons. Bitcoin has become the most popular cryptocurrency in the world due to its sudden rise in value and acceptance within the international marketplace. You might be wondering: What does cloud computing...
HP charts a better path to simplified, just-in-time, and pan-IT support improvements -- despite dynamic and complex IT environments. Much of the attention to coping with mega IT challenges such as cloud, bring your own device (BYOD), mobile applications, and big data focuses on adopti...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE